3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
20
Carcinoma, Renal Cell
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Endometrial Neoplasms
7
Neoplasms
4
Biliary Tract Neoplasms
4
Uterine Cervical Neoplasms
3
Neuroendocrine Tumors
3
Melanoma
3
Liver Neoplasms
3
Vulvar Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
von Hippel-Lindau Disease
1
Thyroid Carcinoma, Anaplastic
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Penile Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Kidney Neoplasms
1
Interventions
paricalcitol
1
mitazalimab
1
Specimen Handling
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Losartan
1
Leucovorin
1
Irinotecan
1
Hydroxychloroquine
1
Glucose
1
Gemcitabine
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Contrast Media
1
Capecitabine
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
lenvatinib
×
90 days
×
Clear all
No trials found.